Navigation Links
Advanced Life Sciences Joins NASDAQ Capital Market
Date:9/21/2007

CHICAGO, Sept. 21 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), has received approval from the NASDAQ Listings Qualifications Staff to transfer the listing of its common stock to the NASDAQ Capital Market from the NASDAQ Global Market. The transfer is effective as of the open of the Market today. The Company continues to be listed and traded under the symbol "ADLS."

(Logo: http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGO )

"Advanced Life Sciences currently meets all of the requirements for continued listing on the NASDAQ Capital Market," said Michael T. Flavin, Ph.D., chairman and chief executive officer. "We believe this transfer is in the best interest of all shareholders and feel the lower cost and listing requirements of the NASDAQ Capital Market better meet our needs as a public company."

The NASDAQ Capital Market includes over 550 issuers of a wide range of capitalization sizes. A NASDAQ Capital Market security satisfies all applicable qualification requirements for NASDAQ securities, and all companies listed on the NASDAQ Capital Market must meet certain financial requirements and adhere to NASDAQ's corporate governance standards.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and inflammation. The Company's lead candidate, cethromycin, is a novel once-a-day antibiotic in late-stage clinical development for the treatment of respiratory tract infections including CAP. For more information, please visit us on the web at http://www.advancedlifesciences.com.


'/>"/>
SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Innovative device aids in advanced heart failure
2. Advanced STD programs required
3. Light therapy devotes new hope in advanced lung cancer
4. Hope For Patients With Advanced Breast Cancer
5. Race an important links to the risk of advanced colorectal cancer
6. HIV Vaccine Field Trials In Advanced Stage
7. Twin Treatment Could Be Used Increase Survival Rates In Advanced Melanoma
8. NICE supports application of advanced biological therapies as treatment option for acute psoriasis
9. Eddie Thompson Receives Advanced Cancer Treatment
10. PSA Can Predicts The Treatment Response In Advanced Prostate Cancer
11. Rapid Aging of Arteries In People With Advanced Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... 12, 2017 , ... On Saturday, October 21, the Health & Wellness Center ... to raise money for the American Heart Association Heart Walk. Teams of up to ... together to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
Breaking Medicine Technology: